UNH 📈 UnitedHealth - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US91324P1021
UNH: Health, Insurance, Pharmacy, Software, Consulting, Wellness, Benefits
UnitedHealth Group Incorporated is a multifaceted health care company operating in the United States, with a diverse range of services and products that cater to various segments of the population. The company's operations are divided into four main segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment is focused on providing consumer-oriented health benefit plans and services, including health care coverage and health and well-being services, to a wide range of customers, from national employers and public sector employers to small businesses and individuals. This segment also offers specialized services, such as Medicaid plans, children's health insurance programs, and health and dental benefits, to state programs that care for the economically disadvantaged and medically underserved populations.
The Optum Health segment is centered on providing care delivery, care management, wellness, and consumer engagement services, as well as health financial services, to patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. This segment plays a critical role in helping individuals navigate the complex health care system and access the care they need. By leveraging its expertise and resources, Optum Health is able to provide high-quality, cost-effective care that addresses the unique needs of its customers. Additionally, this segment offers a range of services and programs that promote wellness, disease prevention, and health education, which are essential for maintaining good health and preventing chronic diseases.
The Optum Insight segment is focused on providing software and information products, advisory consulting arrangements, and managed services outsourcing contracts to a diverse range of customers, including hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. This segment helps its customers to improve their operational efficiency, reduce costs, and enhance the quality of care they provide. By leveraging its expertise in data analytics, technology, and health care operations, Optum Insight is able to provide actionable insights and solutions that help its customers to make informed decisions and drive better outcomes. The segment's software and information products are designed to support the complex needs of the health care industry, from clinical decision support and revenue cycle management to population health management and health information exchange.
The Optum Rx segment is dedicated to providing pharmacy care services and programs that help individuals manage their medications and improve their health outcomes. This segment offers a range of services, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities. Optum Rx also develops programs in areas such as step therapy, formulary management, drug adherence, and disease/drug therapy management, which are designed to promote safe and effective medication use. By leveraging its expertise in pharmacy care and its extensive network of pharmacies and health care providers, Optum Rx is able to provide high-quality, cost-effective pharmacy services that meet the unique needs of its customers.
UnitedHealth Group Incorporated has a long history of innovation and growth, dating back to its founding in 1974. Today, the company is one of the largest and most diversified health care companies in the United States, with a strong presence in the managed health care industry. The company is headquartered in Minnetonka, Minnesota, and its common stock is listed on the New York Stock Exchange (NYSE) under the ticker symbol UNH. With its diverse range of services and products, UnitedHealth Group Incorporated is well-positioned to continue to play a leading role in the health care industry, driving innovation, improving health outcomes, and reducing costs for its customers and the broader health care system.
Additional Sources for UNH Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
UNH Stock Overview
Market Cap in USD | 520,135m |
Sector | Healthcare |
Industry | Healthcare Plans |
GiC Sub-Industry | Managed Health Care |
IPO / Inception | 1984-10-26 |
UNH Stock Ratings
Growth 5y | 76.8% |
Fundamental | 34.9% |
Dividend | 62.1% |
Rel. Strength Industry | -322 |
Analysts | 4.54/5 |
Fair Price Momentum | 498.33 USD |
Fair Price DCF | 368.16 USD |
UNH Dividends
Dividend Yield 12m | 1.22% |
Yield on Cost 5y | 2.22% |
Annual Growth 5y | 11.98% |
Payout Consistency | 95.1% |
UNH Growth Ratios
Growth Correlation 3m | -17.7% |
Growth Correlation 12m | 63.4% |
Growth Correlation 5y | 88.8% |
CAGR 5y | 12.74% |
CAGR/Mean DD 5y | 2.16 |
Sharpe Ratio 12m | -0.12 |
Alpha | -26.14 |
Beta | 0.90 |
Volatility | 50.87% |
Current Volume | 10956.9k |
Average Volume 20d | 6832.9k |
As of December 21, 2024, the stock is trading at USD 500.13 with a total of 10,956,886 shares traded.
Over the past week, the price has changed by -5.14%, over one month by -14.88%, over three months by -14.89% and over the past year by -5.18%.
Neither. Based on ValueRay Fundamental Analyses, UnitedHealth is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 34.86 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UNH as of December 2024 is 498.33. This means that UNH is currently overvalued and has a potential downside of -0.36%.
UnitedHealth has received a consensus analysts rating of 4.54. Therefor, it is recommend to buy UNH.
- Strong Buy: 19
- Buy: 5
- Hold: 4
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, UNH UnitedHealth will be worth about 548.1 in December 2025. The stock is currently trading at 500.13. This means that the stock has a potential upside of +9.6%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 636.2 | 27.2% |
Analysts Target Price | 558.2 | 11.6% |
ValueRay Target Price | 548.1 | 9.6% |